Bone Mineral Density Changes Among Clinical Subtypes of Parkinson's Disease

Phase

N/A

Condition

Osteopenia

Periodontitis

Osteoporosis

Treatment

N/A

Clinical Study ID

NCT03806517

Ordu University 1

Ages 40-85
All Genders
Accepts Healthy Volunteers

Study Summary

The bone loss in Parkinson's disease (PD) emerges as a non-motor symptom with motor and non-motor outcomes, such as fracture and musculoskeletal pain. Bone mineral density (BMD) is decreasing in patients with PD when compared to sex and age-matched healthy controls. The changes in BMD according to clinical subtypes of PD is unknown. The investigators are planning to compare the BMD status between the tremor dominant and postural instability and gait difficulty type of PD.

Eligibility Criteria

Inclusion

For TDT and PIGDT PD group Inclusion Criteria: Clinical diagnosis of idiopathic Parkinson's disease Age of 40-85 years

Exclusion

Exclusion Criteria: Having additional orthopedic and neurological disorders Having metabolic disease, Havingsteroid drug use For Control group The similar age and sex-matched healthy individuals who have no orthopedic, metabolic andneurological disorders, and steroid use will be included in the study.

Study Design

February 10, 2019

February 28, 2019

Study Description

The investigators are planning to complete this study between January and February 2019. This study will be performed at Ordu University Education and Research Hospital, Neurology Department.

All patients admitted to the outpatient clinic will be evaluated in terms of inclusion criteria. The control group consisted of people who do not have any orthopedic, neurological or metabolic disorders which may affect the BMD.

Connect with a study center

Sevim ACARÖZ CANDAN
Ordu, Altinordu 52100
Turkey
Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.